🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study compares the new long-acting insulin 287 with the marketed insul...
Status
Completed
Location
Profil Institut für Stoffwechselforschung GmbH
Start Date
2018-11-29
Trial ID
NCT03723772
Treatments Being Tested
This study is comparing the concentration of a single dose of insulin icode...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2020-10-01
Trial ID
NCT04582448
Treatments Being Tested
This study compares insulin icodec to different daily insulins in people wi...
Status
Completed
Location
Univ of Alabama Birmingham
Start Date
2021-03-01
Trial ID
NCT04760626
Treatments Being Tested
This study is comparing the effect of a long-acting insulin analogue (insul...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2019-05-07
Trial ID
NCT03945656
Treatments Being Tested
This study compares insulin icodec, an insulin taken once a week to insulin...
Status
Recruiting
Location
Cullman Clinical Trials
Start Date
2025-08-11
Trial ID
NCT07076199
Treatments Being Tested
This study compares insulin icodec (a new insulin taken once a week) to ins...
Status
Completed
Location
Uni of Alabama at Birmingham
Start Date
2020-11-25
Trial ID
NCT04460885
Treatments Being Tested
In this study, the investigational product will be compared with insulin de...
Status
Recruiting
Location
Profil
Start Date
2025-08-15
Trial ID
NCT07146347
Treatments Being Tested
This study compares insulin 287 (a possible new medicine) to insulin glargi...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2019-05-09
Trial ID
NCT03922750
Treatments Being Tested
This study compares insulin icodec (a new insulin taken once a week) to ins...
Status
Completed
Location
American Clinical Trials
Start Date
2021-03-05
Trial ID
NCT04770532
Treatments Being Tested